Micr
The report categorizes the global market for microfluidic device systems chiefly on the basis of four criteria: geography Evgeny Kuznetsov Jersey , industry, application, and materials used in the manufacturing process of microfluidic devices.

On the basis of application, the market for microfluidic devices is segmented into pharmaceutical and life sciences research, point of care testing, environment and industrial T. J. Oshie Jersey , clinical and veterinary diagnostics, and drug delivery. Of these, the largest segment of the microfluidic devices market is the veterinary and clinical diagnostic application segment.

Geographically, the microfluidic devices market is segmented into Asia, North America and Europe, wherein North America dominates the global microfluidic devices market Nicklas Backstrom Jersey , while Asia is a rapidly developing region for the microfluidic devices market.

On the basis of industry, the microfluidic devices market is segmented into in- vitro diagnostics, pharmaceuticals, and medical devices. Among these, in-vitro diagnostics is the largest industry and is estimated to reach US$3.3 bn in 2019.

Get Sample of Report:

;rep_id=1561

The report profiles some of the prominent companies such as Abbott Laboratories, Roche Diagnostics Alex Ovechkin Jersey , Siemens Healthcare, Becton Dickinson and Company, Agilent Technologies, Fluidigm Corporation, Bio-Rad Laboratories, and Johnson & Johnson Cheap Capitals Hats , which are key players in the microfluidic devices market.

The market for microfluidics devices can be expected to rise as microfluidics is an evolving field with a huge potential commercially. With applications in various fields such as cell biology research, protein crystallization, and medicine, microfluidics will remain in the market due to its efficacy in the field of treatment.


Request to View Discount 鈥?p>

;rep_id=1561

The global microfluidic devices market is segmented as follows:

by Material


Glass Polymer Silicon by Industry